Stepstone group executive sells shares worth 8,548
| 694308JU2 | 79.30 2.67 3.26% |
About 62% of 694308JU2's investor base is looking to short. The analysis of the overall prospects from investing in PCG 42 01 JUN 41 suggests that many traders are, at the present time, alarmed. The current market sentiment, together with 694308JU2's historical and current headlines, can help investors time the market. In addition, many technical investors use PCG 42 01 bond news signals to limit their universe of possible portfolio assets.
694308JU2 |
Stepstone group executive sells shares worth 8,548
Read at investing.com
 |
PCG 42 01 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 694308JU2 bond to make a market-neutral strategy. Peer analysis of 694308JU2 could also be used in its relative valuation, which is a method of valuing 694308JU2 by comparing valuation metrics with similar companies.
Peers
694308JU2 Related Equities
| NEOG | Neogen | 3.92 | ||||
| XPOF | Xponential Fitness | 1.70 | ||||
| ARDX | Ardelyx | 0.60 | ||||
| CAH | Cardinal Health | 0.28 | ||||
| CCEC | Capital Clean | 1.83 | ||||
| ABOS | Acumen Pharmaceuticals | 2.63 | ||||
| SMMT | Summit Therapeutics | 4.22 |
Other Information on Investing in 694308JU2 Bond
694308JU2 financial ratios help investors to determine whether 694308JU2 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 694308JU2 with respect to the benefits of owning 694308JU2 security.